The tip of the iceberg?
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This chapter discusses pharmaceutical pricing and reimbursement in Europe, as well as public-private partnerships in drug and vaccine development, and the World Health Organization's Medicines Strategy, which outlined a framework for action in essential drugs and medicines policy 2000–2003.
Abstract
I was a medical student on my first clinical rotation and the patient was a confused elderly male who needed a urinary catheter. The houseman gratefully accepted my offer of assistance and disappeared to attend to other duties. I should have realised that something was amiss when the patient groaned during inflation of the balloon. However, I reasoned that a 16 French catheter couldn't possibly be comfortable, and ignored the signs. Several hours later, the consultant noticed blood seeping around the catheter, and ordered deflation of the intrauretheral balloon.
